Table 3.
Variable | Complementary group 100 mg/day (Mean ± SD) |
Complementary group 50 mg/day (Mean ± SD) |
Placebo group (Mean ± SD) |
P-valuea | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Before | After | Changes | Before | After | Changes | Before | After | Changes | ||
FBS (mg/dl) | 170.33 ± 29.19 | 114.43 ± 21.86 | −55.9 ± 7.9 | 169.86 ± 28.03 | 163.63 ± 23.01 | −6.23 ± 9.4 | 159.56 ± 31.19 | 165.26 ± 32.42 | −5.7 ± 14.9 | 0.002 |
HgA1c (%) | 7.09 ± 0.79 | 5.31 ± 0.70 | −1.78 ± 0.21 | 7.27 ± 1.18 | 7.27 ± 1.15 | 0.00 ± 0.56 | 6.72 ± 1.32 | 6.73 ± 1.35 | −0.35 ± 2.6 | 0.024 |
Serum insulin (μIU/ml) | 15.17 ± 1.78 | 10.45 ± 1.05 | −4.72 ± 0.78 | 14.65 ± 2.00 | 13.88 ± 1.61 | −0.77 ± 0.96 | 12.61 ± 2.52 | 13.14 ± 2.38 | 0.53 ± 1.5 | 0.015 |
HOMA-IR | 0.003 ± 0.001 | 0.0029 ± 0.0005 | 0.003 ± 0.001 | 0.006 ± 0.001 | 0.005 ± 0.001 | 0.0005 ± 0.00072 | 0.005 ± 0.001 | 0.005 ± 0.001 | −0.0003 ± 0.0004 | 0.008 |
HOMA-B | 29.5 ± 7.1 | 30.6 ± 7.4 | −1.08 ± 6.9 | 28.2 ± 5.8 | 27.5 ± 5.2 | 0.6 ± 5.4 | 26.0 ± 8.4 | 26.2 ± 8. | −0.21 ± 3.7 | 0.103 |
QUICKI | 3.57 ± 0.08 | 3.03 ± 0.09 | 0.03 ± 0.08 | 3.08 ± 0.07 | 3.08 ± 0.06 | −0.01 ± 0.05 | 3.1 ± 0.1 | 3.1 ± 0.1 | 0.005 ± 0.07 | 0.061 |
hsCRP (pg/ml) | 4.77 ± 0.52 | 3.39 ± 0.58 | −1.38 ± 1.2 | 4.31 ± 0.54 | 4.15 ± 0.54 | −0.16 ± 0.89 | 4.46 ± 0.51 | 4.42 ± 0.71 | −0.04 ± 1.3 | 0.007 |
TNF-α (ng/ml) | 12.86 ± 0.45 | 11.08 ± 0.52 | −1.78 ± 0.97 | 12.44 ± 0.63 | 12.30 ± 0.64 | −0.14 ± 1.9 | 12.08 ± 0.63 | 12.04 ± 0.68 | −0.04 ± 0.49 | 0.008 |
Adiponectin (μg/l) | 102.08 ± 59 | 159.19 ± 71 | 57.11 ± 29 | 106.21 ± 71 | 122.88 ± 41 | 16.67 ± 85 | 103.19 ± 85 | 105.01 ± 23 | 1.82 ± 13 | 0.010 |
All values are means ± SD.
Obtained from ANOVA test.